A systematic review to evaluate the clinical outcomes in COVID -19 patients on angiotensin converting enzyme inhibitors or angiotensin receptor blockers
Abhinav Grover, Mansi Oberoi
doi: https://doi.org/10.1101/2020.04.29.20085787
Abhinav Grover
1University of California, Irvine School of Medicine, Irvine, California, USA
Mansi Oberoi
2University of South Dakota, Sanford School of Medicine, Sioux Falls, USA
Article usage
Posted May 05, 2020.
A systematic review to evaluate the clinical outcomes in COVID -19 patients on angiotensin converting enzyme inhibitors or angiotensin receptor blockers
Abhinav Grover, Mansi Oberoi
medRxiv 2020.04.29.20085787; doi: https://doi.org/10.1101/2020.04.29.20085787
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (178)
- Cardiovascular Medicine (2594)
- Dermatology (218)
- Emergency Medicine (390)
- Epidemiology (12131)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4026)
- Geriatric Medicine (378)
- Health Economics (670)
- Health Informatics (2604)
- Health Policy (994)
- Hematology (358)
- HIV/AIDS (830)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (426)
- Neurology (3793)
- Nursing (208)
- Nutrition (561)
- Oncology (1983)
- Ophthalmology (575)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (248)
- Palliative Medicine (72)
- Pathology (470)
- Pediatrics (1097)
- Primary Care Research (443)
- Public and Global Health (6467)
- Radiology and Imaging (1375)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (336)
- Surgery (437)
- Toxicology (51)
- Transplantation (185)
- Urology (165)